SCHEMBL7024933

SCHEMBL7024933

CC(C)(C)OC(=O)C[C@H](NC(=O)[C@@H]1CCc2nc3ccccc3c(=O)n21)[C@@H](O)CF

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 3/20 0.48
CASP3 P42574 3/20 0.48
CASP8 Q14790 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
ACACB O00763 2/20 0.34
ACACA Q13085 1/20 0.34
POLB P06746 1/20 0.34
KLK5 Q9Y337 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
ACKR3 P25106 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12529736 1.00 CASP1 (0.48) CASP1CASP3CASP8SMN1; SMN2NPSR1
SCHEMBL12529803 0.88 CASP1 (0.52) CASP1CASP3CASP8NPSR1POLB
SCHEMBL7464642 0.86 CASP3 (0.49) CASP1CASP3CASP8SMN1; SMN2NPSR1
SCHEMBL927372 0.77 CASP1 (0.56) CASP1CASP3CASP8SMN1; SMN2NPSR1
SCHEMBL12529733 0.75 CASP3 (0.52) CASP1CASP3CASP8POLBAPOBEC3A
SCHEMBL5500750 0.71 HCRTR1 (0.42) CASP1CASP3CASP8POLBKLK5
SCHEMBL5500752 0.71 HCRTR1 (0.42) CASP1CASP3CASP8POLBKLK5
SCHEMBL8354504 0.70 CASP3 (0.47) CASP1CASP3CASP8HDAC6ALDH1A1
SCHEMBL12624640 0.69 CASP1 (0.58) CASP1CASP3CASP8SMN1; SMN2NPSR1
SCHEMBL5496996 0.69 CTRB1 (0.52) NPSR1KLK5LMNATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289993-A1 CASPASE INHIBITORS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2003-03-12 EP disclosed
WO-2001094351-A1 CASPASE INHIBITORS AND USES THEREOF VERTEX PHARMACEUTICALS INCORPORATED (US) 2001-12-13 WO disclosed